BIOLASE INC (BIOL)
US0909117022 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.57M | 4.18M | 29.97M | 17.56M | 5.79M | |||
| Receivables | 5.48M | 5.84M | 4.24M | 3.06M | 8.76M | |||
| Inventories | 11.43M | 15.88M | 12.93M | 11.16M | 11.00M | |||
| Other Current Assets | 1.38M | 3.05M | 2.21M | 3.33M | 1.47M | |||
| Total Current Assets | 24.86M | 28.96M | 49.35M | 35.11M | 27.02M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.04M | 6.05M | 2.78M | 2.76M | 1.47M | |||
| Goodwill | 2.93M | 2.93M | 2.93M | 2.93M | 2.93M | |||
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Assets | 268.00K | 260.00K | 220.00K | 230.00K | 430.00K | |||
| Total Non-Current Assets | 10.24M | 9.23M | 5.93M | 5.92M | 4.83M | |||
| TOTAL ASSETS | 35.10M | 38.19M | 55.28M | 41.03M | 31.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 13.47M | |||
| Current Portion Of LT Debt. | 2.27M | 700.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 7.81M | 7.69M | 6.62M | 5.77M | 3.79M | |||
| Accounts Payable | 6.07M | 5.79M | 3.31M | 2.65M | 5.33M | |||
| Other Current Liabilities | 3.52M | 3.64M | 3.92M | 2.80M | 3.19M | |||
| Total Current Liabilities | 19.66M | 17.81M | 13.84M | 11.22M | 25.78M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 11.78M | 13.09M | 13.60M | 16.19M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 80.00K | |||
| Other Non-Current Liabilities | 1.70M | 2.40M | 2.63M | 3.59M | 1.65M | |||
| Total Non-Current Liabilities | 13.48M | 15.49M | 16.24M | 19.78M | 1.73M | |||
| TOTAL LIABILITIES | 33.15M | 33.30M | 30.08M | 31.00M | 27.51M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -316.80M | -296.17M | -267.53M | -251.38M | -234.55M | |||
| Additional Paid In Capital | 317.10M | 301.78M | 293.18M | 261.57M | 235.59M | |||
| Common Shares | 2.21M | 10.00K | 180.00K | 220.00K | 4.00M | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -553.00K | -730.00K | -620.00K | -390.00K | -700.00K | |||
| Shares Outstanding | 3.42M | 80.00K | 60.00K | 40.00K | 10.00K | |||
| Tangible Book Value per Share | -0.93 | 24.50 | 370.83 | 174.50 | -256.00 | |||
| Total Shareholders' Equity | 1.96M | 4.89M | 25.21M | 10.03M | 4.34M | |||
| TOTAL LIABILITIES AND EQUITY | 35.10M | 38.19M | 55.28M | 41.03M | 31.85M | |||
| Statistics | ||||||||
| Debt/Equity | 6.02 | 2.68 | 0.54 | 1.61 | N/A | |||
| Current Ratio | 1.26 | 1.63 | 3.57 | 3.13 | 1.05 | |||
| Return On Assets (ROA) | -107.17% | -75.54% | -30.21% | -83.38% | -56.08% | |||
| Return On Equity (ROE) | -1923.26% | -589.98% | -66.24% | -341.08% | -411.52% | |||
All data in USD